Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: J Pediatr Hematol Oncol. 2015 Jan;37(1):e6–e12. doi: 10.1097/MPH.0000000000000148

Figure 1.

Figure 1

Cumulative incidence of second malignant neoplasms (SMNs) in survivors of neuroblastoma (y-axis) by histologic class of SMN (acute myeloid leukemia/myelodysplastic syndrome (AML/MDS), sarcoma, and carcinoma) relative to time since diagnosis of neuroblastoma in years (x-axis).